Carcinoma, Pancreatic Ductal - 23 Studies Found
| Completed |
: Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. : Carcinoma, Pancreatic Ductal : 2007-05-07 :
|
| Recruiting |
: According CTC to Compare the Influences of Different Methods to Remove the PDAC :
: 2015-05-14 :
|
| Terminated |
: Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer :
: 2014-09-15 : |
| Completed |
: Continuous Monitoring on the General Ward :
: |
| Terminated |
: Amatuximab for High Mesothelin Cancers :
|
| Active, not recruiting |
: Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma : Metastatic Pancreatic Ductal Adenocarcinoma : 2015-10-20 :
|
| Active, not recruiting |
: Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma : Metastatic Pancreatic Ductal Adenocarcinoma : 2015-08-27 :
|
| Completed |
: Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer : Pancreatic Ductal Adenocarcinoma : 2012-04-13 : Drug: INNO-206 INNO-206 at a total dose of 350 mg/m2 (260 mg/m2 doxorubicin equivalent) will be administ |
| Enrolling by invitation |
: Clinical Trial of Pancreatic Cancer in Stockholm. : Pancreatic Cancer : 2014-06-11 : Procedure: Pancreatic Surgery Surgical removal of the pancreatic tumour (cancer) in the intervention gro |